In this session, Dr Nicola Wright will give an overview of her groundbreaking gene therapy trial for CD3 SCID and the potential implications for this innovative approach for both patients and Canada. Don’t miss the opportunity to hear about one of the most promising advances in precision medicines happening on our doorstep!
Hear from Dr. Kevin Lee, recipient of the Immunity Canada Immunology Resident Research Grant, as he shares findings from his study: Understanding the Needs and Barriers to Care of Adolescents and Young Adults with Primary Immunodeficiency in Canada. This session will highlight key insights into the unique challenges faced by this age group and discuss implications for improving transitions in care and support services.
Dr. Nicola Wright
Dr. Nicola Wright completed training in Pediatric Hematology/Oncology with a focus on Immunology at Cincinnati Children’s Hospital and Stanford University, following which she returned to Calgary to practice benign hematology and clinical immunology. She holds the Barb Ibbotson Chair in Pediatric Hematology. She advocated for newborn screening for SCID and sickle cell disease in Alberta, both of which were introduced in 2019. She is excited to be collaborating with Dr. Kohn, UCLA, to develop a Canadian gene therapy clinical trial for CD3delts SCID, one of the more common types of SCID in Alberta. She was recently awarded a CIHR Clinical Trials Fund grant for the project. Other research interests include development of the Canadian Inborn Errors of Immunity Registry, and various projects on rare blood and immune disorders and autoimmune blood diseases.
Dr. Kevin Lee
Dr. Kevin Lee completed his medical school and internal medicine training at the University of Alberta, then completed his subspecialty training in Allergy and Immunology at the University of British Columbia. He currently works in a community clinic in Vancouver and at the BC Children’s Allergy Clinic, with affiliations with the local hospitals and with UBC. Outside the clinic, he serves on the executive board
for the BC Society of Allergy and Immunology.
During his training, he and his mentor, Dr. Catherine Biggs, received a research grant from ImmUnity Canada to assess the barriers of health care in adolescents and young adults with PID; he will present some results of this study during the conference.
See the full agenda and get your tickets today: